CollPlant Biotechnologies LtdCLGN
| Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | - | 3 | 13 | 30 |
---|
Short term cash deposits | - | - | 30 | - |
---|
Restricted deposit | - | 0 | 0 | 0 |
---|
Trade receivables | - | 1 | 0 | 0 |
---|
Other accounts receivable and prepaid expenses | - | 0 | 0 | 1 |
---|
Inventories | - | 1 | 1 | 1 |
---|
Total current assets | 5 | 6 | 45 | 32 |
---|
Restricted deposit | - | 0 | 0 | 0 |
---|
Operating lease right-of-use assets | - | 3 | 3 | 3 |
---|
Property and equipment, net | 2 | 2 | 3 | 3 |
---|
Intangible assets, net | - | 0 | 0 | 0 |
---|
Total non-current assets | 6 | 5 | 6 | 6 |
---|
Total assets | 11 | 11 | 51 | 38 |
---|
Trade payables | - | 1 | 1 | 1 |
---|
Operating lease liabilities | - | 0 | 1 | 1 |
---|
Deferred revenues | - | 0 | 0 | - |
---|
Accrued liabilities and other | - | 2 | 1 | 1 |
---|
Total current liabilities | 3 | 3 | 3 | 3 |
---|
Operating lease liabilities | - | 3 | 3 | 2 |
---|
Total non-current liabilities | 3 | 3 | 3 | 2 |
---|
Total liabilities | 7 | 6 | 6 | 5 |
---|
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2022 and December 31, 2021; issued and outstanding: 11,186,481 and 10,772,024 ordinary shares as of December 31, 2022 and December 31, 2021, respectively | - | 3 | 5 | 5 |
---|
Additional paid in capital | - | 76 | 114 | 118 |
---|
Currency translation differences | - | -1 | -1 | -1 |
---|
Accumulated deficit | - | -73 | -73 | -90 |
---|
Total shareholders’ equity | - | 4 | 45 | 32 |
---|
Total liabilities and shareholders’ equity | - | 11 | 51 | 38 |
---|